Elizabeth Buck, Ph.D., is the co-founder, Chief Scientific Officer (CSO), and Executive Vice President of Black Diamond Therapeutics.
Elizabeth Buck, Ph.D., is the co-founder, Chief Scientific Officer (CSO), and Executive Vice President of Black Diamond Therapeutics. This clinical-stage oncology company, founded in 2014, specializes in developing MasterKey therapies for genetically defined tumors.
Full founder directory · Investor directory · Company funding database · Fundraising library